Code | 07294 | ||||||||||
MA number | 13/0294/11-S | ||||||||||
Product Form: | plc ifo 1x2500 mg (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Orpha-Devel Handels und Vertriebs GmbH, Austria | ||||||||||
Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 29.04.2011 |
Pediatric warnings: | Yes |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 26.03.2019 |